KEGG   DRUG: Clofarabine
Entry
D03546                      Drug                                   
Name
Clofarabine (JAN/USAN/INN);
Clolar (TN)
Product
  Generic
Formula
C10H11ClFN5O3
Exact mass
303.0534
Mol weight
303.6774
Structure
Simcomp
Class
Antineoplastic
 DG02018  Antimetabolite
  DG01958  Nucleic acid derivative, antineoplastic
   DG01439  Arabinofuranosyl type antineoplastic
Remark
Therapeutic category: 4229
ATC code: L01BB06
Product: D03546<JP/US>
Efficacy
Antineoplastic, Antimetabolite
  Disease
Acute lymphoblastic leukemia [DS:H00001 H00002]
Target
RRM1 [HSA:6240] [KO:K10807]
POLA [HSA:5422 23649] [KO:K02320 K02321]
  Pathway
hsa00230  Purine metabolism
hsa00240  Pyrimidine metabolism
hsa03030  DNA replication
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01B ANTIMETABOLITES
    L01BB Purine analogues
     L01BB06 Clofarabine
      D03546  Clofarabine (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Antineoplastics
  Antimetabolites
   Clofarabine
    D03546  Clofarabine (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   422  Antimetabolites
    4229  Others
     D03546  Clofarabine (JAN/USAN/INN)
Drug groups [BR:br08330]
 Antineoplastic
  DG02018  Antimetabolite
   DG01958  Nucleic acid derivative, antineoplastic
    DG01439  Arabinofuranosyl type antineoplastic
     D03546  Clofarabine
Drug classes [BR:br08332]
 Antineoplastic
  DG02018  Antimetabolite
   D03546  Clofarabine
Target-based classification of drugs [BR:br08310]
 Enzymes
  Oxidoreductases (EC1)
   Ribonucleoside-diphosphate reductase
    RRM1
     D03546  Clofarabine (JAN/USAN/INN) <JP/US>
  Transferases (EC2)
   DNA polymerase
    POLA
     D03546  Clofarabine (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D03546
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D03546
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D03546
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D03546
Other DBs
CAS: 123318-82-1
PubChem: 47205855
ChEBI: 681569
PDB-CCD: CFB[PDBj]
LigandBox: D03546
NIKKAJI: J457.798A
LinkDB
KCF data

ATOM        20
            1   C1y C    23.0884  -19.5314
            2   C1y C    24.4740  -19.5314
            3   C1y C    24.9021  -18.2136
            4   O2x O    23.7812  -17.3992
            5   C1y C    22.6603  -18.2136
            6   N5x N    27.3020  -19.5991
            7   C8y C    27.3020  -18.2136
            8   N4y N    26.1021  -17.5208
            9   C1b C    21.4603  -17.5208
            10  O1a O    20.2604  -18.2136
            11  X   F    25.2884  -20.6523
            12  O1a O    22.2740  -20.6523
            13  C8y C    28.5019  -20.2919
            14  N5x N    29.7019  -19.5991
            15  C8y C    29.7019  -18.2136
            16  C8y C    28.5019  -17.5208
            17  C8x C    26.5178  -16.1371
            18  N5x N    28.0862  -16.1367
            19  X   Cl   28.5019  -21.6790
            20  N1a N    30.9035  -17.5196
BOND        22
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     6   7 1
            7     7   8 1
            8     3   8 1 #Up
            9     5   9 1 #Up
            10    9  10 1
            11    2  11 1 #Up
            12    1  12 1 #Down
            13    6  13 2
            14   13  14 1
            15   14  15 2
            16   15  16 1
            17    7  16 2
            18    8  17 1
            19   16  18 1
            20   17  18 2
            21   13  19 1
            22   15  20 1

» Japanese version   » Back

DBGET integrated database retrieval system